These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7634558)

  • 1. Maintaining long-term control of blood pressure: the role of improved compliance.
    Bittar N
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 12-6. PubMed ID: 7634558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance, electronic monitoring and antihypertensive drugs.
    Mallion JM; Baguet JP; Siche JP; Tremel F; de Gaudemaris R
    J Hypertens Suppl; 1998 Jan; 16(1):S75-9. PubMed ID: 9534102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved blood pressure control by monitoring compliance with antihypertensive therapy.
    Waeber B; Vetter W; Darioli R; Keller U; Brunner HR
    Int J Clin Pract; 1999; 53(1):37-8. PubMed ID: 10344064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
    Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].
    Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R
    Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence.
    Cramer JA
    Am J Manag Care; 1998 Nov; 4(11):1563-8. PubMed ID: 10338902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming barriers to effective blood pressure control in patients with hypertension.
    Düsing R
    Curr Med Res Opin; 2006 Aug; 22(8):1545-53. PubMed ID: 16870079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-perceived problems, compliance, and the outcome of hypertension treatment.
    Enlund H; Jokisalo E; Wallenius S; Korhonen M
    Pharm World Sci; 2001 Apr; 23(2):60-4. PubMed ID: 11411446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating safety, efficacy and compliance into economic value for controlled release dosage forms.
    Cramer MP; Saks SR
    Pharmacoeconomics; 1994 Jun; 5(6):482-504. PubMed ID: 10150160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial.
    Christensen A; Christrup LL; Fabricius PE; Chrostowska M; Wronka M; Narkiewicz K; Hansen EH
    J Hypertens; 2010 Jan; 28(1):194-200. PubMed ID: 19770778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension.
    Burnier M
    Blood Press Monit; 2000; 5 Suppl 1():S31-4. PubMed ID: 10904240
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.